Stanford engineers have developed and tested a nanostructured thin film material that upconverts infrared to visible light and combines electrical and non-linear optical properties in the same layer.
Stanford researchers have invented a fully water-soluble, orange hydrazine sensor that can robustly quantify the toxin hydrazine in liquids such as drinking water, waste water (treated and untreated), and bodily fluids.
Researchers in Prof. Irving Weissman's laboratory have developed cell culture techniques to rapidly and efficiently derive pure populations of mesodermal cells from human pluripotent stem cells (hPSCs).
Stanford researchers developed a single plasmid reprogramming system called CoMiP carrying codon optimized sequences of the canonical reprogramming factors (OKSM) and short hairpin RNA against p53.
Engineers in Prof. Anthony Kovscek's laboratory have developed a patented, dual-function core holder apparatus that can be used in enhanced oil recovery (EOR) experiments to both saturate the core and perform spontaneous imbibition analysis.
Researchers in the Stanford Genome Technology Center have developed a robust, high-throughput, high-efficiency functional genomics platform to generate precisely edited genome variant libraries and then readily isolate and identify thousands of individual strains en masse
Researchers at Stanford have developed new fluorescent sensors to detect and monitor gastrointestinal (GI) permeability. GI permeability can be correlated with the prognosis of GI disease, thus earlier detection may lead to better patient outcomes.
Researchers at Stanford and their colleagues have developed cell culture media, known as LPM-3D, to grow a pure population of multipotent lung stem cells in culture.
Stanford researchers in the Blau Lab have discovered that telomere length can be used as a biomarker for cardiomyopathy diagnosis and drug screening with cardiomyocytes.
Researchers at Stanford have developed methods to enhance bone healing in diabetic patients, who often suffer from impaired fracture healing due to a deficiency in hedgehog signaling in their skeletal stem cells.
Researchers at Stanford have developed methods to classify and treat MYC-driven hematopoietic cancers. The MYC oncogene drives the proliferation and survival of many hematopoietic cancers. These cancers are highly aggressive and do not respond to conventional chemotherapies.
Stanford researchers have demonstrated a new passive cavitation mapping algorithm based on sound localization of multiple scatters of cavitation. It shows improved resolution as compared to existing passive cavitation mapping algorithms based on a basic beamforming.